Yael Morgenstern
University Health Network(CA)Princess Margaret Cancer Centre(CA)
Publications by Year
Research Areas
Chronic Myeloid Leukemia Treatments, Acute Myeloid Leukemia Research, Cell death mechanisms and regulation, Hematopoietic Stem Cell Transplantation, Wnt/β-catenin signaling in development and cancer
Most-Cited Works
- → A Senescence-Inflammatory Switch from Cancer-Inhibitory to Cancer-Promoting Mechanism(2013)235 cited
- → CKIα ablation highlights a critical role for p53 in invasiveness control(2011)212 cited
- → Casein kinase 1‐epsilon or 1‐delta required for Wnt‐mediated intestinal stem cell maintenance(2017)24 cited
- → Dose‐adjusted EPOCH‐R is not superior to sequential R‐CHOP/R‐ICE as a frontline treatment for newly diagnosed primary mediastinal B‐cell lymphoma: Results of a bi‐center retrospective study(2021)11 cited
- → Direct oral anticoagulants versus enoxaparin in patients with atrial fibrillation and active cancer(2021)3 cited
- → Acute myeloid leukemia drug-tolerant persister cells survive chemotherapy by transiently increasing plasma membrane rigidity, that also increases their sensitivity to immune cell killing(2024)3 cited
- → The Contribution of Bone Marrow Stromal Cells to Leukemia Evolution: Differential Support of Leukemia Cell Growth at Diagnosis and Remission(2015)1 cited
- → AML Drug Tolerant Persister (DTP) Cells Survive Chemotherapy By Transiently Altering Cellular Lipidomics to Increase Plasma Membrane Rigidity, but Also Increases Sensitivity to Immune Cell Killing(2023)1 cited
- → Hematopoietic Transplantation and Cellular Therapy in Acute Lymphoblastic Leukemia(2023)